NowPatient review
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated July 2026
Semaglutide here is $1,349/mo (brand Wegovy) — $1150 above our category median of $199.
- Semaglutide
- $1,349/mo (brand Wegovy)
- Tirzepatide
- $1,069/mo (brand Mounjaro, promotional rate)
- Coverage
- Coverage not published
- Brand-name
- Yes
- Oral option
- Yes
- Verification
- Not independently listed
Best for: People who want brand-name GLP-1 access without a compounded route.
MatchScript's take: Our #376 pick of 537 — one of the few with a non-injection route.
The factor breakdown
NowPatient on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $1,349/mo (brand Wegovy) puts Budget Fit at a below-par 36 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 57 on Speed to Start.
NowPatient adds an oral/sublingual route and brand-name access on top of injectables, for an exceptional 95 on Formulary Match.
Support lands at a solid 83 — solid, standard support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
Thinner public disclosure than the top of the ranking keeps Transparency at a below-par 28.
Pricing in context
How NowPatient's monthly price sits against the category median and the cheapest provider we track.
| Monthly price | Semaglutide | Tirzepatide |
|---|---|---|
| NowPatientthis providerVisit | $1,349/mo (brand Wegovy)+$1150 vs median | $1,069/mo (brand Mounjaro, promotional rate)+$795 vs median |
| Category median430 tracked | $199/mo | $274/mo |
| Cheapest trackedMondaeVisit | $87 per 28 days (13 charges a year) | $126 per 28 days (13 charges a year) |
What we like
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
The caveats
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Who it's for — and who should skip it
NowPatient is for people who want brand-name GLP-1 access without a compounded route.
Skip it if that doesn't sound like you. A closer fit may be Lttl (Match Score 58) — or take the quiz to see where NowPatient lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
NowPatient against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | NowPatientthis provider | CoreAge Rxour #1 | Lttlclosest scorer |
|---|---|---|---|
| Sema price | $1,349/mo (brand Wegovy) | $99/mo at every dose | $216/mo |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable + oral + brand | Injectable | Injectable + oral |
| Match Score | 58 · C | 91 · A− | 58 · C |
NowPatient, answered
Is NowPatient legit?
NowPatient is a real, operating GLP-1 telehealth program. LegitScript certification is the third-party check worth asking for — look for the seal on their site and confirm your prescriber is US-licensed at intake. It dispenses FDA-approved brand-name medication rather than the compounded formulas most programs here sell, which is why its pricing sits higher.
How much does NowPatient cost?
NowPatient lists compounded semaglutide from $1,349/mo (brand Wegovy) and tirzepatide from $1,069/mo (brand Mounjaro, promotional rate) — above our category median of $199/mo. These are the provider's public figures at our last review (July 2026); confirm on their site, since some teaser tiers step up after month one.
Does NowPatient ship to my state?
NowPatient doesn't publish a full state list, so confirm your state is covered during intake before you pay.
NowPatient vs Lttl — which should I pick?
They score within a few points of each other: NowPatient at 58/100 and Lttl at 58/100, so neither wins on the headline number. NowPatient is the better fit for people who want brand-name GLP-1 access without a compounded route. Lttl suits shoppers who want every commitment tier priced openly, plus a low-dose microdose option. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified July 2026 from NowPatient's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on NowPatient's site. Not medical advice; see our disclosure.
Semaglutide here is $1,349/mo (brand Wegovy) — $1150 above our category median of $199. Tirzepatide is $1,069/mo (brand Mounjaro, promotional rate). Its strongest suit is the range of medication it offers. Best suited to people who want brand-name GLP-1 access without a compounded route. If that is not you, Lttl is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest NowPatient here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Somira Health#377 | 58 | $190/mo (compounded) | $240/mo | Coverage not published | Alternatives | Visit |
| TD Tele-Doc Weight Loss#378 | 58 | Not disclosed | Not disclosed | 2 states | Alternatives | Visit |
| Unique Physique#379 | 58 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Bioverse#380 FDA issued Bioverse, Inc. dba Bioverse a warning letter in September 2025. See FDA's warning-letter database. | 58 | $131/mo | $232/mo | Coverage not published | Alternatives | Visit |
| Elevated Health#381 FDA issued Elevate Your Wellness LLC, dba Elevated a warning letter in September 2025. See FDA's warning-letter database. | 58 | $300/mo | $364/mo | Coverage not published | Alternatives | Visit |
| Roboclinic#382 | 58 | $179/mo (12-month plan, compounded) | $399/mo | Coverage not published | Alternatives | Visit |
| Voxy#383 | 58 | $179/mo (compounded) | $299/mo (compounded) | Coverage not published | Alternatives | Visit |
| Reset Solutions#384 | 58 | $169/mo | Not disclosed | 1 state | Alternatives | Visit |
| Stealth Health#385 | 58 | $100/mo | $140/mo | Coverage not published | Alternatives | Visit |
| FormBlends#386 | 57 | $179/mo | $233/mo | Coverage not published | Alternatives | Visit |
| CaliberRx#387 | 57 | $232/mo | $232/mo | Coverage not published | Alternatives | Visit |
| BodyLogicMD#388 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Call-On-Doc#389 | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Empower Pharmacy#390 FDA issued Empower Clinic Services, LLC dba Empower Pharmacy a warning letter in April 2025. See FDA's warning-letter database. | 57 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Hello Alpha#391 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Heros Health#392 | 57 | $178/mo | $279/mo | Coverage not published | Alternatives | Visit |
| Joi + Blokes#393 FDA issued Joi and Blokes dba Joi + Blokes a warning letter in June 2026. See FDA's warning-letter database. | 57 | $202/mo | $303/mo | Coverage not published | Alternatives | Visit |
| Peptivo#394 | 57 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Signos#395 | 57 | $271/mo | $334/mo | Coverage not published | Alternatives | Visit |
| TeleSlim Clinic#396 | 57 | $248/mo | Not disclosed | 6 states | Alternatives | Visit |
| EOS Health#397 | 57 | $202/mo | $303/mo | 40 states | Alternatives | Visit |
| LevelUp Rx#398 | 57 | $152/mo | $254/mo | Coverage not published | Alternatives | Visit |
| Remi Meds#399 | 57 | $249/mo (0.25 mg dose, compounded) | $349/mo (2.25 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| Brello Health#400 | 57 | $158/mo | $197/mo | 35 states | Alternatives | Visit |
NowPatient is ranked on our best semaglutide providers, best tirzepatide providers, best GLP-1 programs, best brand-name GLP-1 providers and best oral GLP-1 providers boards, scored on the same six factors as every other provider there.